Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction
Cardiovascular Drugs and Therapy · 2026-12 · 40 (6) · 2183-2194
DOI: 10.1007/s10557-026-07910-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 28.07.2026. Verfasst von Yun Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine, Xinxiang Central Hospital, No. 56 Jinsui Avenue, Weibin District, Henan, 453000, China. Hauptthemen laut MEDLINE: MicroRNAs, STAT3 Transcription Factor, RNA, Circular, Human Umbilical Vein Endothelial Cells. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Endothelial dysfunction is the initiating factor in atherosclerosis and is a persistent feature throughout the entire course of acute myocardial infarction (AMI). Circular RNA (circRNA) fulfils a vital regulatory role in cardiovascular diseases, including AMI. AIM: To investigate the expression and clinical significance of circ_0089762 in AMI, and to elucidate the molecular mechanism in regulating hypoxia/reoxygenation (H/R)-induced damage in human umbilical vein endothelial cells (HUVECs). METHODS: Serum levels of circ_0089762, miR-938, and STAT3 were measured by RT-qPCR. A model H/R injury model was established in HUVECs, and by transfecting to modulate circ_0089762, miR-938, assess cell viability, apoptosis, migration, oxidative stress, and inflammation levels. The targeting relationship was validated using dual-luciferase assays. Rescue experiments were conducted to verify the regulatory axis. RESULTS: circ_0089762 is hyper-expressed in AMI, and it has certain diagnostic accuracy in distinguishing AMI patients from healthy individuals, as well as being associated with major adverse cardiovascular events (MACE). H/R treatment can upregulate circ_0089762 expression. Silencing circ_0089762 enhances cell viability, inhibits apoptosis, improves migration, and reduces MDA levels whilst increasing NO and SOD levels, and suppresses the release of inflammatory factors. circ_0089762 directly targets miR-938, and miR-938 directly targets STAT3. Inhibition of miR-938 reverses the protective effects of circ_0089762 knockdown, and further knockdown of STAT3 restores the endothelial protective effects. CONCLUSION: circ_0089762 exacerbates H/R-induced apoptosis, oxidative stress, and inflammatory response in HUVECs by regulating miR-938 and STAT3 expression. circ_0089762 may act as a potential biomarker for the diagnosis, prognostic assessment, and targeted treatment of AMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Medicine, Xinxiang Central Hospital, No. 56 Jinsui Avenue, Weibin District, Henan, 453000, China.
- Cardiovascular Medicine, Xinxiang Central Hospital, No. 56 Jinsui Avenue, Weibin District, Henan, 453000, China. liuzhiqiangdr@163.com.
Zitieren
APA
Zhao, Y., Lu, P., Lu, X., & Liu, Z. (2026). Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction. Cardiovascular Drugs and Therapy, 40(6), 2183-2194. https://doi.org/10.1007/s10557-026-07910-6
Vancouver
Zhao Y, Lu P, Lu X, Liu Z. Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction. Cardiovascular Drugs and Therapy. 2026;40(6):2183-2194. doi:10.1007/s10557-026-07910-6
BibTeX
@article{Zhao2026,
author = {Zhao, Yun and Lu, Pengfei and Lu, Xing and Liu, Zhiqiang},
title = {Circulating Circ_0089762 Predicts Adverse Outcomes in Acute Myocardial Infarction Via Regulating miR‑938/STAT3‑Mediated Endothelial Dysfunction},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
volume = {40},
number = {6},
pages = {2183--2194},
doi = {10.1007/s10557-026-07910-6}
}
EUVIMED